vs
CARTERS INC(CRI)与Healthpeak Properties(DOC)财务数据对比。点击上方公司名可切换其他公司
CARTERS INC的季度营收约是Healthpeak Properties的1.1倍($757.8M vs $719.4M),Healthpeak Properties净利率更高(73.2% vs 1.5%,领先71.6%),Healthpeak Properties同比增速更快(3.1% vs -0.1%),Healthpeak Properties自由现金流更多($357.0M vs $-144.1M)
卡特公司是美国知名儿童服饰设计与销售龙头企业,由威廉·卡特于1865年创立,主打婴童服饰品类,凭借多年的行业深耕,在北美儿童服饰市场拥有较高的认可度与市场份额。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
CRI vs DOC — 直观对比
营收规模更大
CRI
是对方的1.1倍
$719.4M
营收增速更快
DOC
高出3.2%
-0.1%
净利率更高
DOC
高出71.6%
1.5%
自由现金流更多
DOC
多$501.1M
$-144.1M
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $757.8M | $719.4M |
| 净利润 | $11.6M | $114.0M |
| 毛利率 | 45.1% | — |
| 营业利润率 | 3.8% | 17.4% |
| 净利率 | 1.5% | 73.2% |
| 营收同比 | -0.1% | 3.1% |
| 净利润同比 | -80.1% | 2406.4% |
| 每股收益(稀释后) | $0.32 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CRI
DOC
| Q4 25 | — | $719.4M | ||
| Q3 25 | $757.8M | $705.9M | ||
| Q2 25 | $585.3M | $694.3M | ||
| Q1 25 | $629.8M | $702.9M | ||
| Q4 24 | — | $698.0M | ||
| Q3 24 | — | $700.4M | ||
| Q2 24 | — | $695.5M | ||
| Q1 24 | — | $606.6M |
净利润
CRI
DOC
| Q4 25 | — | $114.0M | ||
| Q3 25 | $11.6M | $-117.1M | ||
| Q2 25 | $446.0K | $31.7M | ||
| Q1 25 | $15.5M | $42.8M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $85.9M | ||
| Q2 24 | — | $146.0M | ||
| Q1 24 | — | $6.7M |
毛利率
CRI
DOC
| Q4 25 | — | — | ||
| Q3 25 | 45.1% | 58.6% | ||
| Q2 25 | 48.1% | 60.2% | ||
| Q1 25 | 46.2% | 61.1% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 60.0% | ||
| Q2 24 | — | 60.6% | ||
| Q1 24 | — | 59.8% |
营业利润率
CRI
DOC
| Q4 25 | — | 17.4% | ||
| Q3 25 | 3.8% | 9.2% | ||
| Q2 25 | 0.7% | 5.7% | ||
| Q1 25 | 4.1% | 7.7% | ||
| Q4 24 | — | -2.2% | ||
| Q3 24 | — | 14.1% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | — | 3.7% |
净利率
CRI
DOC
| Q4 25 | — | 73.2% | ||
| Q3 25 | 1.5% | -16.6% | ||
| Q2 25 | 0.1% | 4.6% | ||
| Q1 25 | 2.5% | 6.1% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 21.0% | ||
| Q1 24 | — | 1.1% |
每股收益(稀释后)
CRI
DOC
| Q4 25 | — | $0.16 | ||
| Q3 25 | $0.32 | $-0.17 | ||
| Q2 25 | $0.01 | $0.05 | ||
| Q1 25 | $0.43 | $0.06 | ||
| Q4 24 | — | $0.02 | ||
| Q3 24 | — | $0.12 | ||
| Q2 24 | — | $0.21 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $184.2M | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $864.6M | $7.5B |
| 总资产 | $2.5B | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势,按日历期对齐
现金及短期投资
CRI
DOC
| Q4 25 | — | $467.5M | ||
| Q3 25 | $184.2M | $91.0M | ||
| Q2 25 | $338.2M | $89.4M | ||
| Q1 25 | $320.8M | $70.6M | ||
| Q4 24 | — | $119.8M | ||
| Q3 24 | — | $180.4M | ||
| Q2 24 | — | $106.9M | ||
| Q1 24 | — | $101.8M |
总债务
CRI
DOC
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.8B |
股东权益
CRI
DOC
| Q4 25 | — | $7.5B | ||
| Q3 25 | $864.6M | $7.6B | ||
| Q2 25 | $853.9M | $7.9B | ||
| Q1 25 | $847.2M | $8.2B | ||
| Q4 24 | — | $8.4B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.8B | ||
| Q1 24 | — | $8.9B |
总资产
CRI
DOC
| Q4 25 | — | $20.3B | ||
| Q3 25 | $2.5B | $19.6B | ||
| Q2 25 | $2.5B | $19.8B | ||
| Q1 25 | $2.3B | $19.8B | ||
| Q4 24 | — | $19.9B | ||
| Q3 24 | — | $20.0B | ||
| Q2 24 | — | $20.2B | ||
| Q1 24 | — | $20.5B |
负债/权益比
CRI
DOC
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-128.0M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $-144.1M | $357.0M |
| 自由现金流率自由现金流/营收 | -19.0% | 49.6% |
| 资本支出强度资本支出/营收 | 2.1% | 124.4% |
| 现金转化率经营现金流/净利润 | -11.04× | 10.99× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CRI
DOC
| Q4 25 | — | $1.3B | ||
| Q3 25 | $-128.0M | $315.0M | ||
| Q2 25 | $40.3M | $363.5M | ||
| Q1 25 | $-48.6M | $279.4M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $318.2M | ||
| Q2 24 | — | $316.2M | ||
| Q1 24 | — | $152.6M |
自由现金流
CRI
DOC
| Q4 25 | — | $357.0M | ||
| Q3 25 | $-144.1M | — | ||
| Q2 25 | $24.1M | — | ||
| Q1 25 | $-59.0M | — | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
CRI
DOC
| Q4 25 | — | 49.6% | ||
| Q3 25 | -19.0% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | -9.4% | — | ||
| Q4 24 | — | 47.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CRI
DOC
| Q4 25 | — | 124.4% | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | — | 105.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
CRI
DOC
| Q4 25 | — | 10.99× | ||
| Q3 25 | -11.04× | — | ||
| Q2 25 | 90.37× | 11.48× | ||
| Q1 25 | -3.13× | 6.52× | ||
| Q4 24 | — | 235.43× | ||
| Q3 24 | — | 3.71× | ||
| Q2 24 | — | 2.17× | ||
| Q1 24 | — | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRI
| Sales Channel Directly To Consumer | $362.3M | 48% |
| Sales Channel Through Intermediary | $283.8M | 37% |
| Other | $110.4M | 15% |
| Gift Cards | $1.3M | 0% |
DOC
暂无分部数据